• Company
• Samsung Biologics record-high earnings of ₩166.8 in Q2
• by An, Kyung-Jin Jul 28, 2021 05:55am

• Company
• Domestic DDP-4 inhibitors fare better amid sales decline
• by Kim, Jin-Gu Jul 28, 2021 05:55am

• Policy
• Regulations are required on GMP violations
• by Lee, Jeong-Hwan Jul 28, 2021 05:54am

• Company
• 3 generics for Champix have been withdrawn in just one year
• by Lee, Tak-Sun Jul 28, 2021 05:54am

• Policy
• The weighted average price may vary when charging Xarelto
• by Lee, Hye-Kyung Jul 28, 2021 05:54am

• Policy
• Moderna vaccine by Samsung Biologics is supplied worldwide
• by Kim, Jung-Ju Jul 27, 2021 05:36am

• Policy
• When will Phase 3 trials of K-COVID-19 vaccines begin?
• by Lee, Tak-Sun Jul 27, 2021 05:35am

• Company
• 19% of valsartan Rxs disappear 3 years after impurity issue
• by An, Kyung-Jin Jul 27, 2021 05:35am

• Company
• Sales in the SGLT-2 diabetes drug market rose by 10%
• by Kim, Jin-Gu Jul 27, 2021 05:35am

• Company
• Ultomiris can be prescribed in general hospitals
• by Eo, Yun-Ho Jul 26, 2021 05:51am